Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00916474 · ClinicalTrials.gov registry record

Virology Follow up Study in Subjects Previously Treated With Telaprevir

A clinical trial of Hepatitis C, sponsored by Vertex Pharmaceuticals Incorporated.

Completed
Registry status
408
Enrollment target
20
Study locations

NCT00916474 is a study of Hepatitis C that has completed, run by Vertex Pharmaceuticals Incorporated. The registered enrollment target is 408 participants, below the 1,886-participant average among 106 other Hepatitis C trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00916474, a study of Hepatitis C, has completed, sponsored by Vertex Pharmaceuticals Incorporated.

COMPLETED
Registry status
408 participants
Enrollment target
20
Study locations

Study Summary

Observational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time.

Conditions Studied

Hepatitis C

Interventions

  • DRUG telaprevir

Study Locations (20)

California

  • California - Coronado
  • California - Los Angeles
  • California - San Francisco

Florida

  • Florida - Gainsville
  • Florida - Jacksonville
  • Florida - Miami

Colorado

  • Colorado - Denver
  • Colorado - Englewood

New York

  • New York - Manhasset
  • New York - New York

North Carolina

  • North Carolina - Chapel Hill
  • North Carolina - Durham

Alabama

  • Alabama - Birmingham

Georgia

  • Georgia - Altanta

Maryland

  • Maryland - Baltimore

Trial Details

FieldValue
Enrollment Target 408 participants
Start Date 2009-06
Est. Completion 2013-12

Sponsor

Vertex Pharmaceuticals Incorporated

191 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00916474

The ClinicalTrials.gov registry entry for NCT00916474 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,886-participant average among 106 other Hepatitis C trials with a reported enrollment target (78% lower). The listed sponsor is Vertex Pharmaceuticals Incorporated, which has 191 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which telaprevir is the first listed.

NCT00916474 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Colorado.

Frequently Asked Questions

What is clinical trial NCT00916474 about?

NCT00916474 is a clinical study titled "Virology Follow up Study in Subjects Previously Treated With Telaprevir". Observational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time.

What is the current status of trial NCT00916474?

This trial is currently completed. The enrollment target is 408 participants. The study started on 2009-06. Estimated completion is 2013-12.

What conditions does trial NCT00916474 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT00916474?

The interventions under investigation include: telaprevir (DRUG).

Who is sponsoring clinical trial NCT00916474?

This trial is sponsored by Vertex Pharmaceuticals Incorporated, which has 191 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00916474 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.